S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

NCT00109928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: cisplatin
DRUG: etoposide
DRUG: gemcitabine
DRUG: methylprednisolone

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]